Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01082679 · ClinicalTrials.gov registry record · Phase 2
Treatment for Opioid Dependent Offenders
A Phase 2 study of Opioid Dependence, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT01082679: Completed Phase 2 study of Opioid Dependence, sponsored by University of Wisconsin, Madison.
NCT01082679 is a Phase 2 study of Opioid Dependence that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 16 participants, below the 158-participant average among 29 other Opioid Dependence trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01082679, a Phase 2 study of Opioid Dependence, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study is examining the feasibility of a primary care and a specialist treatment (methadone clinic) model of treatment for 15 offenders who are part of two community supervision programs: Drug Court and the Treatment Alternative Program (TAP) in Dane County. The questions addressed by future larger studies based upon the current pilot-feasibility study will center around whether access to primary health care as opposed to more traditional methadone treatment services will improve the health and criminal justice outcomes for participants.
Primary Outcome
This study is focused on Dane County Drug Treatment Court and Treatment Alternative Program participants. The study will determine feasibility of monitoring participants in primary care as opposed to the usual standard of specialty care. Feasibility of monitoring participants will be studied in terms of retention rate of participants in the study
Conditions Studied
Interventions
- DRUG Methadone
- DRUG buprenorphine (Suboxone)
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-05 |
| Phase | Phase 2 |
What the finished NCT01082679 record still lists
NCT01082679 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 158-participant average among 29 other Opioid Dependence trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Opioid Dependence appearing as the primary indexed condition, and to 2 interventions - of which Methadone is the first listed.
NCT01082679 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01082679 about?
NCT01082679 is a clinical study titled "Treatment for Opioid Dependent Offenders". This pilot study is examining the feasibility of a primary care and a specialist treatment (methadone clinic) model of treatment for 15 offenders who are part of two community supervision programs: Drug Court and the Treatment Alternative Program (TAP) in Dane County. The questions addressed by futu...
What is the current status of trial NCT01082679?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2009-06. Estimated completion is 2011-05.
What conditions does trial NCT01082679 study?
This clinical trial studies the following conditions: Opioid Dependence.
What interventions are being tested in trial NCT01082679?
The interventions under investigation include: Methadone (DRUG), buprenorphine (Suboxone) (DRUG).
Who is sponsoring clinical trial NCT01082679?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01082679 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01082679's enrollment target sits among peer trials
16 26th of 29 higher than 3 of 29 other Opioid Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
ACTIVE NOT RECRUITING · Phase 2
-
Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults
COMPLETED · Phase 2
-
Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers
COMPLETED · Phase 2
-
The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1
COMPLETED · Phase 2
-
Neuromodulation and Cognitive Training in Opioid Use Disorder
RECRUITING · NA
-
Intervening With Opioid-Dependent MothersMothers and Infants
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia